Gigamon (GIMO) Jumps 5.37% on February 16

Equities Staff |

Gigamon (GIMO) was among the biggest gainers on the Russell 2000 for Tuesday February 16 as the stock popped 5.37% to $23.75, representing a gain of $1.21 per share. Some 244,269 shares traded hands on 2,519 trades, compared with an average daily volume of 402,972 shares out of a total float of 34.02 million. The stock opened at $22.84 and traded with an intraday range of $23.76 to $22.71.

After today's gains, Gigamon reached a market cap of $808.04 million. Gigamon has had a trading range between $34.80 and $18.93 over the last year, and it had a 50-day SMA of $24.98 and a 200-day SMA of $26.92.

The stock has a P/E Ratio of 131.8.

Gigamon Inc develops a solution that delivers visibility of traffic across networks. Its solution, Unified Visibility Fabric, consists of a distributed system of nodes that enables level of visibility, modification and control of network traffic.

Gigamon is based out of Santa Clara, CA and has some 371 employees. Its CEO is Paul A. Hooper.

For a complete fundamental analysis analysis of Gigamon, check out’s Stock Valuation Analysis report for GIMO. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Beleave Inc.

Beleave Inc is a biotech company. The Company is engaged in the production of medical marijuana under the Marihuana for Medical Purposes Regulations outlined by Health Canada.

Private Markets


Pinterest is a visual discovery and planning tool. Users ("Pinners") use the site and apps to get ideas for their future, such as recipes, places to travel, and products to…


Cloudera offers enterprises a new data platform built on the Apache Hadoop open-source software package. Hadoop is a data-management platform that can consolidate data in a single repository for comprehensive…